Quarterly report · Q2
4480.TEDINET S100ROAG
Period2023-01-01 → 2023-06-30
Filed2023-08-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥10.7bn | 2023-01-01 → 2023-06-30 | Cons. | Net sales |
| Revenue | ¥14.2bn | 2022-01-01 → 2022-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥7.0bn | 2022-01-01 → 2022-06-30 | Cons. | Net sales |
| Operating income | ¥2.4bn | 2023-01-01 → 2023-06-30 | Cons. | Operating income |
| Operating income | ¥1.3bn | 2022-01-01 → 2022-06-30 | Cons. | Operating income |
| Ordinary income | ¥2.8bn | 2023-01-01 → 2023-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥1.5bn | 2022-01-01 → 2022-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.4bn | 2022-01-01 → 2022-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥2.8bn | 2023-01-01 → 2023-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.4bn | 2022-01-01 → 2022-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.9bn | 2023-01-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.0bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥969m | 2022-01-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.9bn | 2023-01-01 → 2023-06-30 | Cons. | Profit loss |
| Net income | ¥970m | 2022-01-01 → 2022-06-30 | Cons. | Profit loss |
| Total assets | ¥24.5bn | at 2023-06-30 | Cons. | Assets |
| Total assets | ¥21.8bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥20.9bn | at 2022-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥7.3bn | at 2023-06-30 | Cons. | Liabilities |
| Total liabilities | ¥6.6bn | at 2022-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥17.2bn | at 2023-06-30 | Cons. | Net assets |
| Net assets / equity | ¥15.2bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥14.8bn | at 2022-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥16.0bn | at 2023-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥14.4bn | at 2022-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥15.9bn | at 2023-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥14.4bn | at 2022-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥14.5bn | at 2022-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥14.0bn | at 2021-12-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥2.8bn | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.0bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.3bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥805m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥751m | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥366m | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥385m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥927m | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥449m | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥58.48 | 2023-01-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥47.29 | 2023-04-01 → 2023-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥31.77 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥30.32 | 2022-01-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥31.29 | 2022-04-01 → 2022-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥57.65 | 2023-01-01 → 2023-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥31.16 | 2022-01-01 → 2022-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥29.71 | 2022-01-01 → 2022-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 69.9% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 69.1% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.2% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 34
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-01-01 → 2023-06-30 | −¥1m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-01-01 → 2023-06-30 | −¥1m |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-06-30 | −¥1.2bn |
| jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥2.9bn |
| jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥2.9bn |
| jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | −¥38m |
| jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥178m |
| jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥178m |
| jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segment | segment profit | 2023-01-01 → 2023-06-30 | −¥121m |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥7.7bn |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥7.7bn |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥1m |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥3.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-01-01 → 2023-06-30 | ¥10.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-01-01 → 2023-06-30 | ¥10.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥1m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-01-01 → 2023-06-30 | ¥3.6bn |
| Reconciling Itemsreconciling | revenue | 2022-01-01 → 2022-06-30 | −¥1m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-01-01 → 2022-06-30 | −¥1m |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-06-30 | −¥1.1bn |
| jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥1.5bn |
| jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥1.5bn |
| jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segment | segment profit | 2022-01-01 → 2022-06-30 | −¥224m |
| jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥160m |
| jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥160m |
| jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segment | segment profit | 2022-01-01 → 2022-06-30 | −¥24m |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥5.3bn |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥5.3bn |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | revenue intersegment | 2022-01-01 → 2022-06-30 | ¥1m |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥2.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-01-01 → 2022-06-30 | ¥7.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-01-01 → 2022-06-30 | ¥7.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-01-01 → 2022-06-30 | ¥1m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-01-01 → 2022-06-30 | ¥2.3bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 520
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 32738600 | |
| Number of shares held | CurrentQuarterInstant_No1MajorShareholdersMember | 5989000 | |
| Shareholding ratio | CurrentQuarterInstant_No1MajorShareholdersMember | 0.1856 | |
| Number of shares held | CurrentQuarterInstant_No2MajorShareholdersMember | 3515000 | |
| Shareholding ratio | CurrentQuarterInstant_No2MajorShareholdersMember | 0.1089 | |
| Number of shares held | CurrentQuarterInstant_No3MajorShareholdersMember | 3455000 | |
| Shareholding ratio | CurrentQuarterInstant_No3MajorShareholdersMember | 0.1071 | |
| Number of shares held | CurrentQuarterInstant_No4MajorShareholdersMember | 2052000 | |
| Shareholding ratio | CurrentQuarterInstant_No4MajorShareholdersMember | 0.0636 | |
| Number of shares held | CurrentQuarterInstant_No5MajorShareholdersMember | 1633000 | |
| Shareholding ratio | CurrentQuarterInstant_No5MajorShareholdersMember | 0.0506 | |
| Number of shares held | CurrentQuarterInstant_No6MajorShareholdersMember | 1440000 | |
| Shareholding ratio | CurrentQuarterInstant_No6MajorShareholdersMember | 0.0446 | |
| Number of shares held | CurrentQuarterInstant_No7MajorShareholdersMember | 933000 | |
| Shareholding ratio | CurrentQuarterInstant_No7MajorShareholdersMember | 0.0289 | |
| Number of shares held | CurrentQuarterInstant_No8MajorShareholdersMember | 840000 | |
| Shareholding ratio | CurrentQuarterInstant_No8MajorShareholdersMember | 0.0260 | |
| Number of shares held | CurrentQuarterInstant_No9MajorShareholdersMember | 677000 | |
| Shareholding ratio | CurrentQuarterInstant_No9MajorShareholdersMember | 0.0210 | |
| Number of shares held | CurrentQuarterInstant_No10MajorShareholdersMember | 441000 | |
| Shareholding ratio | CurrentQuarterInstant_No10MajorShareholdersMember | 0.0137 | |
| Number of shares held | CurrentQuarterInstant | 20978000 | |
| Shareholding ratio | CurrentQuarterInstant | 0.6501 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 322554 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 32255400 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 13000 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 32738600 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 322554 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 470200 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 470200 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.0144 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 470200 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 470200 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.0144 | |
| Cash and deposits | Prior1YearInstant | 14422000000 | JPY |
| Cash and deposits | CurrentQuarterInstant | 16005000000 | JPY |
| Accounts receivable trade | Prior1YearInstant | 1265000000 | JPY |
| Accounts receivable trade | CurrentQuarterInstant | 1732000000 | JPY |
| Merchandise and finished goods | Prior1YearInstant | 154000000 | JPY |
| Merchandise and finished goods | CurrentQuarterInstant | 146000000 | JPY |
| Work in process | Prior1YearInstant | 12000000 | JPY |
| Work in process | CurrentQuarterInstant | 1000000 | JPY |
| Prepaid expenses | Prior1YearInstant | 148000000 | JPY |
| Prepaid expenses | CurrentQuarterInstant | 208000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |